Correlation Between ZyVersa Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on ZyVersa Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for ZyVersa Therapeutics and Terns Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ZyVersa and Terns is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Terns Pharmaceuticals. In addition to that, ZyVersa Therapeutics is 2.23 times more volatile than Terns Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about 0.03 per unit of volatility. If you would invest 586.00 in Terns Pharmaceuticals on August 27, 2024 and sell it today you would lose (7.00) from holding Terns Pharmaceuticals or give up 1.19% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
ZyVersa Therapeutics vs. Terns Pharmaceuticals
Performance |
Timeline |
ZyVersa Therapeutics |
Terns Pharmaceuticals |
ZyVersa Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ZyVersa Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite ZyVersa Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |